ACS Biomarker
Amsterdam
About ACS Biomarker
ACS Biomarker is an emerging biomarker development company aiming to discover and develop biomarkers that improve prognosis and management of cardiac disease. Well designed biomarkers can provide major value for patients and importantly advance health care as they can signify subtle molecular mechanisms that underlie disease, so that early recognition of pathological disorders can limit the increase in healthcare cost associated with treatment of these diseases. Equally important, biomarkers are needed in therapeutic drug development to appreciate the balance between beneficial and adverse actions of novel drugs at earlier stages of development, thus increasing the efficacy of drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (May 2011)
- Website: acsbiomarker.com
- Phone: 31 43 388 5811
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/acs-biomarker-3360631 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.